# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA5182963 | 16a; [(R,S)-MHPMPG] | CC50 | > | 100 | uM | ALA5124939 | nM | Homo sapiens | |||
2. | ALA5182963 | 16a; [(R,S)-MHPMPG] | EC90 | = | 38.06 | uM | ALA5124938 | uM | Hepatitis B virus | |||
3. | ALA5182963 | 16a; [(R,S)-MHPMPG] | EC50 | = | 0.14 | uM | ALA5124938 | 6.85 | nM | Hepatitis B virus | ||
4. | ALA5182963 | 16a; [(R,S)-MHPMPG] | Ratio CC50/EC50 | = | 5 | ALA5124937 | ||||||
5. | ALA5182963 | 16a; [(R,S)-MHPMPG] | Ratio CC50/EC50 | = | 7 | ALA5124936 | ||||||
6. | ALA5182963 | 16a; [(R,S)-MHPMPG] | CC50 | = | 228.06 | uM | ALA5124935 | nM | Homo sapiens | |||
7. | ALA5182963 | 16a; [(R,S)-MHPMPG] | EC50 | = | 42.13 | uM | ALA5124934 | 4.38 | nM | Human immunodeficiency virus 2 | ||
8. | ALA5182963 | 16a; [(R,S)-MHPMPG] | EC50 | = | 32.53 | uM | ALA5124933 | 4.49 | nM | Human immunodeficiency virus 1 | ||
9. | ALA5182963 | 16a; [(R,S)-MHPMPG] | CC50 | = | 21.61 | uM | ALA5124926 | nM | Homo sapiens | |||
10. | ALA5182963 | 16a; [(R,S)-MHPMPG] | MCC | = | 300.08 | uM | ALA5124925 | nM | Homo sapiens | |||
11. | ALA5182963 | 16a; [(R,S)-MHPMPG] | EC50 | = | 3.6 | uM | ALA5124924 | 5.44 | nM | Human alphaherpesvirus 3 | ||
12. | ALA5182963 | 16a; [(R,S)-MHPMPG] | EC50 | = | 2.4 | uM | ALA5124923 | 5.62 | nM | Human alphaherpesvirus 3 | ||
13. | ALA5182963 | 16a; [(R,S)-MHPMPG] | EC50 | = | 5.37 | uM | ALA5124922 | 5.27 | nM | Human betaherpesvirus 5 | ||
14. | ALA5182963 | 16a; [(R,S)-MHPMPG] | EC50 | = | 5.37 | uM | ALA5124921 | 5.27 | nM | Human betaherpesvirus 5 |